Lawsuit Overview
May 14, 2012 (Shareholders Foundation) -- An investor in NASDAQ:CHTP shares filed a lawsuit against directors of Chelsea Therapeutics International Ltd. over alleged breaches of fiduciary duties over certain statements made in connection with Chelsea Therapeutics’ new drug Northera. According to the complaint the plaintiff alleged that Chelsea Therapeutics International Ltd. lied abo...
You must register (for free) or login to view the entire case.